small molecule

PEDIAMYCIN

ERYTHROMYCIN ETHYLSUCCINATE

Loss of exclusivityloss of exclusivity
CompanyARBOR PHARMACEUTICALS LLC

Drug detail

Brand namePEDIAMYCIN
Active ingredientERYTHROMYCIN ETHYLSUCCINATE
StrengthEQ 200MG BASE/5ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PEDIAMYCIN patent cliff — loss of exclusivity — | CliffBio